TP53 and cancer: The study conducted by Pinto-de-Sousa et al., (2004) on 163 patients with cancer showed that mutation in p53 gene was associated with the vascular invasion, lymphatic metastasis, and higher five-year survival, and the expression of this gene was associated with more aggressive characteristics in the stomach carcinoma.